GLP-1s are changing US healthcare, should everyone be on them?

GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.

You might also like

Society

World Bank estimates Venezuela earthquakes caused $19.6bn in damage

Society

Southport killer Axel Rudakubana moved to Broadmoor psychiatric hospital

Society

More than 20,000 evacuated after intense wildfire in France